ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,966Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 1692

$1.33M Total Retail Price of All Prescriptions

Rank: 14 out of 1692

674 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 674 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

10% of this provider’s 674 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 17,211 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
LEVOTHYROXINE SODIUM 950 752 1 4
SIMVASTATIN 897 658 2 1
AMLODIPINE BESYLATE 728 646 3 3
METFORMIN HCL 714 506 4 8
GABAPENTIN 641 461 5 13
LISINOPRIL 618 474 6 2
OMEPRAZOLE 612 414 7 5
FUROSEMIDE 555 438 8 7
CARVEDILOL 462 389 9 24
METOPROLOL TARTRATE 433 380 10 10
TRAMADOL HCL 422 307 11 16
LOSARTAN POTASSIUM 366 305 12 17
ALLOPURINOL 347 276 13 30
BENAZEPRIL HCL 328 292 14 69
POTASSIUM CHLORIDE 296 223 15 20
CRESTOR 277 203 16 26
HYDROCODONE-ACETAMINOPHEN 260 210 S3 17 6
GLIMEPIRIDE 244 204 18 32
PRAVASTATIN SODIUM 241 201 19 12
CARAFATE 212 156 20 290
PANTOPRAZOLE SODIUM 211 174 21 39
LANTUS 197 139 22 57
FLUTICASONE PROPIONATE 187 108 23 27
SYMBICORT 183 95 24 166
TAMSULOSIN HCL 181 148 25 31
HYDROCHLOROTHIAZIDE 178 147 26 9
ATORVASTATIN CALCIUM 176 164 27 11
RANITIDINE HCL 176 105 27 28
HYDRALAZINE HCL 174 155 29 92
GEMFIBROZIL 170 126 30 98
TIZANIDINE HCL 168 91 31 127
WARFARIN SODIUM 160 133 32 14
ACETAZOLAMIDE 157 101 33 355
NEXIUM 157 116 33 25
SINGULAIR 156 101 35 79
HYDROXYZINE HCL 150 105 R 36 182
CYMBALTA 149 94 37 51
JANUVIA 149 111 37 72
CLOPIDOGREL 149 141 37 43
AMITRIPTYLINE HCL 149 51 R 37 58
DIOVAN 147 105 41 42
SPIRONOLACTONE 134 92 42 74
COLCRYS 131 103 43 154
ADVAIR DISKUS 127 99 44 45
NATEGLINIDE 126 108 45 304
LIDOCAINE 126 94 45 341
CLONIDINE HCL 125 107 47 46
QUETIAPINE FUMARATE 123 98 48 62
CELEBREX 118 80 49 103
ESCITALOPRAM OXALATE 114 101 50 76
AVODART 113 106 51 173
PLAVIX 108 102 52 66
SPIRIVA 104 55 53 44
PREDNISONE 98 78 54 35
NOVOLOG MIX 70-30 98 76 54 285
DOXAZOSIN MESYLATE 97 78 56 83
INSULIN SYRINGE 97 66 56 93
ZETIA 97 69 56 68
SUCRALFATE 94 70 59 172
KLOR-CON M20 93 70 60 48
POLYETHYLENE GLYCOL 3350 91 66 61 64
PROBENECID 88 70 10 62 393
HUMALOG MIX 75-25 88 75 62 263
TRAZODONE HCL 88 67 62 33
ENALAPRIL MALEATE 86 71 65 71
MIRTAZAPINE 86 86 65 53
ROPINIROLE HCL 85 71 67 101
MONTELUKAST SODIUM 84 59 68 144
SERTRALINE HCL 83 78 69 22
METOPROLOL SUCCINATE 83 66 69 18
TOPIRAMATE 81 21 71 164
LISINOPRIL-HYDROCHLOROTHIAZIDE 80 39 72 19
MECLIZINE HCL 79 68 73 124
LANTUS SOLOSTAR 79 59 73 102
CEFACLOR 77 44 75 405
PROAIR HFA 77 39 75 40
KLOR-CON M10 76 68 77 106
PEN NEEDLE 76 52 77 168
ZOLPIDEM TARTRATE 75 58 79 23
DONEPEZIL HCL 74 74 80 29
BYSTOLIC 74 63 80 129
ACTOS 74 52 80 117
LOVASTATIN 72 60 83 37
NYSTATIN-TRIAMCINOLONE 71 53 84 220
LEVEMIR 71 58 84 184
NAMENDA 71 71 84 50
LOSARTAN-HYDROCHLOROTHIAZIDE 68 50 87 38
ATENOLOL 67 66 88 15
NOVOLOG MIX 70-30 FLEXPEN 66 32 89 312
CIPROFLOXACIN HCL 66 52 89 65
METOCLOPRAMIDE HCL 65 31 91 146
LIDODERM 62 36 92 138
DIGOXIN 61 55 93 85
GLIPIZIDE 61 39 93 47
MEGESTROL ACETATE 58 51 R 95 185
VERAPAMIL ER 57 47 96 90
BENICAR 57 57 96 217
BUSPIRONE HCL 57 32 96 122
PRANDIN 57 57 96 433
DIOVAN HCT 56 36 100 73
LEVEMIR FLEXPEN 56 39 100 149
NASONEX 56 39 100 245
SYNTHROID 56 56 100 59
DICYCLOMINE HCL 54 41 104 259
NOVOLOG 54 49 104 120
AMLODIPINE BESYLATE-BENAZEPRIL 53 40 106 67
TRIAMCINOLONE ACETONIDE 53 28 106 105
HYDROXYZINE PAMOATE 53 0 R 106 211
LOVAZA 52 39 109 176
THEOPHYLLINE ANHYDROUS 51 34 110 210
PROMETHAZINE HCL 51 30 R 110 81
GLYBURIDE 50 44 R 112 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 10, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.